Skip to main content
CDT
NASDAQ Life Sciences

CDT Equity Inc. Implements 1-for-25 Reverse Stock Split to Boost Share Price

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
8
Price
$0.44
Mkt Cap
$2.183M
52W Low
$0.442
52W High
$168
Market data snapshot near publication time

Summary

CDT Equity Inc. will implement a 1-for-25 reverse stock split effective March 26, 2026, to increase its share price, likely to maintain its Nasdaq listing.


Key Events

  • Reverse Stock Split Details

    CDT Equity Inc. filed a certificate of amendment to effectuate a 1-for-25 reverse stock split of its common stock, effective March 26, 2026, at 5:00 p.m. Eastern Time.

  • Nasdaq Trading Adjustment

    The common stock is expected to begin trading on The Nasdaq Capital Market on a reverse stock split-adjusted basis on March 27, 2026, under the existing ticker symbol 'CDT'.

  • Fractional Shares Handled by Cash Payment

    No fractional shares will be issued; stockholders entitled to a fractional share will receive a cash payment based on the closing price on March 26, 2026.

  • Share Count Reduction

    After the reverse stock split, the number of outstanding shares of common stock will be reduced to approximately 4,722,450.


Analysis

CDT Equity Inc. is executing a significant 1-for-25 reverse stock split, a common maneuver for companies whose stock price has fallen below exchange minimums, likely to maintain its Nasdaq listing. While it increases the per-share price, it does not change the company's overall market capitalization or fundamental value. Investors should be aware that reverse splits often precede further price declines if the underlying business issues are not resolved. The company's stock is currently trading near its 52-week low, underscoring the urgency of this action. The reduction in outstanding shares could lead to increased volatility.

At the time of this filing, CDT was trading at $0.44 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.2M. The 52-week trading range was $0.44 to $168.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CDT - Latest Insights

CDT
May 28, 2026, 4:33 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.950
Real-time Price: $0.696 info
Change: -$0.254 (-27%) info
Market Cap: $3.381M info
CDT
May 28, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.950
Real-time Price: $0.696 info
Change: -$0.254 (-27%) info
Market Cap: $3.381M info
CDT
May 15, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.73
Real-time Price: $0.696 info
Change: -$1.03 (-60%) info
Market Cap: $3.381M info
CDT
May 14, 2026, 8:47 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $1.90
Real-time Price: $0.696 info
Change: -$1.20 (-63%) info
Market Cap: $3.381M info
CDT
May 06, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.09
Real-time Price: $0.696 info
Change: -$1.39 (-67%) info
Market Cap: $3.381M info
CDT
May 01, 2026, 5:11 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $2.18
Real-time Price: $0.696 info
Change: -$1.48 (-68%) info
Market Cap: $3.381M info
CDT
Apr 21, 2026, 9:56 PM EDT
Filing Type: S-3
Importance Score:
9
Price at Filing: $3.35
Real-time Price: $0.696 info
Change: -$2.65 (-79%) info
Market Cap: $3.381M info
CDT
Apr 15, 2026, 5:01 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $4.67
Real-time Price: $0.696 info
Change: -$3.97 (-85%) info
Market Cap: $3.381M info
CDT
Apr 02, 2026, 4:15 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $3.80
Real-time Price: $0.696 info
Change: -$3.10 (-82%) info
Market Cap: $3.381M info
CDT
Mar 30, 2026, 9:21 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $7.40
Real-time Price: $0.696 info
Change: -$6.70 (-91%) info
Market Cap: $3.381M info